[Efficiency of nebulised magnesium sulphate in infective exacerbations of chronic obstructive pulmonary disease].

Author: ArsevenOrhan, CömertŞule, EceTurhan, KıyanEsen, OkumuşGülfer, İşseverHalim

Paper Details 
Original Abstract of the Article :
INTRODUCTION: Conflicting results has been achieved in a small number of clinical studies evaluating the efficiency of magnesium sulphate (MS) in COPD exacerbations. We aimed to investigate the efficiency of nebulised MS in COPD exacerbations. PATIENTS AND METHODS: Twenty patients who met the study...See full text at original site
Dr.Camel IconDr.Camel's Paper Summary Blogラクダ博士について

ラクダ博士は、Health Journal が論文の内容を分かりやすく解説するために作成した架空のキャラクターです。
難解な医学論文を、専門知識のない方にも理解しやすいように、噛み砕いて説明することを目指しています。

* ラクダ博士による解説は、あくまで論文の要点をまとめたものであり、原論文の完全な代替となるものではありません。詳細な内容については、必ず原論文をご参照ください。
* ラクダ博士は架空のキャラクターであり、実際の医学研究者や医療従事者とは一切関係がありません。
* 解説の内容は Health Journal が独自に解釈・作成したものであり、原論文の著者または出版社の見解を反映するものではありません。


引用元:
https://doi.org/10.5578/tt.9854

データ提供:米国国立医学図書館(NLM)

Nebulized Magnesium Sulfate for COPD Exacerbations: A Promising Adjunctive Therapy

This study investigates the efficacy of nebulized magnesium sulfate (MS) in treating infective exacerbations of chronic obstructive pulmonary disease (COPD). The researchers conducted a randomized controlled trial involving 20 patients with COPD exacerbations who received standard treatment with oxygen, antibiotics, and oral corticosteroids. One group received additional nebulized MS along with ipratropium bromide (IB), while the other group received a placebo. The study found that nebulized MS provided additional relief of dyspnea in COPD exacerbations compared to placebo, with significant improvements in dyspnea scores and peak expiratory flow rates (PEFRs) in the MS group. The study concluded that nebulized MS is a safe, affordable, and feasible adjunctive therapy for COPD exacerbations.

Expanding the Treatment Options for COPD Exacerbations

This study provides evidence supporting the potential benefits of nebulized MS as an adjunctive therapy for COPD exacerbations. The findings suggest that MS can improve dyspnea and lung function, offering a valuable treatment option for patients experiencing acute COPD exacerbations.

Optimizing COPD Management: A Multimodal Approach

This study emphasizes the importance of a multimodal approach to COPD management, integrating both standard therapies and promising adjunctive therapies. By exploring new treatment strategies, researchers can continue to improve the lives of patients with COPD and reduce the burden of this chronic disease.

Dr.Camel's Conclusion

This study is a reminder that even in the vast desert of chronic respiratory diseases, there are hidden oases of therapeutic options. Nebulized magnesium sulfate holds potential as a valuable tool for improving the lives of COPD patients. It's a testament to the ongoing search for innovative therapies and solutions in the field of respiratory medicine.

Date :
  1. Date Completed 2016-12-15
  2. Date Revised 2019-11-13
Further Info :

Pubmed ID

27266281

DOI: Digital Object Identifier

10.5578/tt.9854

Related Literature

SNS
PICO Info
in preparation
Languages

Turkish

Positive IndicatorAn AI analysis index that serves as a benchmark for how positive the results of the study are. Note that it is a benchmark and requires careful interpretation and consideration of different perspectives.

This site uses cookies. Visit our privacy policy page or click the link in any footer for more information and to change your preferences.